153 related articles for article (PubMed ID: 22968430)
1. miRNA-218 contributes to the regulation of D-glucuronyl C5-epimerase expression in normal and tumor breast tissues.
Prudnikova TY; Mostovich LA; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
Epigenetics; 2012 Oct; 7(10):1109-14. PubMed ID: 22968430
[TBL] [Abstract][Full Text] [Related]
2. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
Mostovich LA; Prudnikova TY; Kondratov AG; Gubanova NV; Kharchenko OA; Kutsenko OS; Vavilov PV; Haraldson K; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
Epigenetics; 2012 Aug; 7(8):930-9. PubMed ID: 22805760
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.
Prudnikova TY; Soulitzis N; Kutsenko OS; Mostovich LA; Haraldson K; Ernberg I; Kashuba VI; Spandidos DA; Zabarovsky ER; Grigorieva EV
Cancer Med; 2013 Oct; 2(5):654-61. PubMed ID: 24403231
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of human D-glucuronyl C5-epimerase in breast cancer.
Grigorieva E; Eshchenko T; Rykova VI; Chernakov A; Zabarovsky E; Sidorov SV
Int J Cancer; 2008 Mar; 122(5):1172-6. PubMed ID: 17985344
[TBL] [Abstract][Full Text] [Related]
5. D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo.
Grigorieva EV; Prudnikova TY; Domanitskaya NV; Mostovich LA; Pavlova TV; Kashuba VI; Zabarovsky ER
Br J Cancer; 2011 Jun; 105(1):74-82. PubMed ID: 21654676
[TBL] [Abstract][Full Text] [Related]
6. GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population.
Belyavskaya VA; Prudnikova TY; Domanitskaya NV; Litviakov NV; Maksimov VN; Cherdyntseva NV; Grigorieva EV
Gene; 2017 Sep; 628():224-229. PubMed ID: 28734894
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells.
Prudnikova TY; Mostovich LA; Domanitskaya NV; Pavlova TV; Kashuba VI; Zabarovsky ER; Grigorieva EV
Cancer Cell Int; 2010 Aug; 10():27. PubMed ID: 20723247
[TBL] [Abstract][Full Text] [Related]
8. D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells.
Rosenberg EE; Prudnikova TY; Zabarovsky ER; Kashuba VI; Grigorieva EV
Tumour Biol; 2014 Apr; 35(4):3237-45. PubMed ID: 24264315
[TBL] [Abstract][Full Text] [Related]
9. The human D-glucuronyl C5-epimerase gene is transcriptionally activated through the beta-catenin-TCF4 pathway.
Ghiselli G; Agrawal A
Biochem J; 2005 Sep; 390(Pt 2):493-9. PubMed ID: 15853773
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional study of D-glucuronyl C5-epimerase.
Qin Y; Ke J; Gu X; Fang J; Wang W; Cong Q; Li J; Tan J; Brunzelle JS; Zhang C; Jiang Y; Melcher K; Li JP; Xu HE; Ding K
J Biol Chem; 2015 Feb; 290(8):4620-4630. PubMed ID: 25568314
[TBL] [Abstract][Full Text] [Related]
11. Hepatic glucuronyl C5-epimerase combats obesity by stabilising GDF15.
He F; Jiang H; Peng C; Wang T; Xiao R; Chen M; Song N; Du Z; Wang H; Ding X; Shao Y; Fang J; Zang Y; Hua R; Li J; Ding K
J Hepatol; 2023 Sep; 79(3):605-617. PubMed ID: 37217020
[TBL] [Abstract][Full Text] [Related]
12. D-glucuronyl C5-epimerase acts in dorso-ventral axis formation in zebrafish.
Ghiselli G; Farber SA
BMC Dev Biol; 2005 Sep; 5():19. PubMed ID: 16156897
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA regulation of progesterone receptor in breast cancer.
Gilam A; Shai A; Ashkenazi I; Sarid LA; Drobot A; Bickel A; Shomron N
Oncotarget; 2017 Apr; 8(16):25963-25976. PubMed ID: 28404930
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
17. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
Yin Y; Shen C; Xie P; Cheng Z; Zhu Q
Breast; 2016 Apr; 26():1-10. PubMed ID: 27017236
[TBL] [Abstract][Full Text] [Related]
18. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
[TBL] [Abstract][Full Text] [Related]
19. Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer.
Hannafon BN; Sebastiani P; de las Morenas A; Lu J; Rosenberg CL
Breast Cancer Res; 2011 Mar; 13(2):R24. PubMed ID: 21375733
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
Wilk G; Braun R
Nucleic Acids Res; 2018 Feb; 46(3):1089-1101. PubMed ID: 29294105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
